Evaluation of a Rapid Automated Assay for Analysis of von Willebrand Ristocetin Cofactor Activity

Abstract

A commercially available turbidometric assay has been evaluated for the measurement of von Willebrand factor ristocetin cofactor activity (VWF:RCo). The assay is simple, rapid, and can be cost-effectively performed on automated coagulation analyzers. This study’s aim is to illustrate the performance of the automated VWF:RCo assay and its capacity to identify patients with von Willebrand disease (VWD). By direct comparison with a conventional VWF:RCo assay, performed on an aggregometer, the concordance between the two assays was 96%. With minor modifications, the automated assay showed a detection level of 0.03 kIU/L with linearity to 2.00 kIU/L. The imprecision of the automated assay was reduced compared to the conventional assay procedure with CV of 6.8% at the 1.00 kIU/L level and 8.6% at the 0.30 kIU/L level. The automated VWF:RCo assay was also suitable as a screening test to detect VWD in patients investigated for the cause of an increased bleeding tendency. In this situation the automated VWF:RCo assay was tested simultaneously with an automated immunoassay for von Willebrand antigen. Receiver operating curves for the diagnosis of VWD showed a greater area under the curve for the automated VWF:RCo assay compared to the immunoassay, 0.98 vs. 0.94, although the difference did not reach significance. In conclusion, the modified automated VWF:RCo assay shows better precision, lower detection limit, is faster to perform with a lower cost per test compared to the conventional aggregometer based VWF:RCo activity method and is an alternative to an antigen immunoassay as a screening test for VWD.

Keywords

von Willebrand factor von Willebrand disease von Willebrand factor ristocetin cofactor activity Automation Method evaluation

References

Rodeghiero F , Castaman G . Congenital von Willebrand disease type 1: Definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol 2001;14:321.

Rodeghiero F . von Willebrand disease: Still an intriguing disorder in the era of molecular medicine. Haemophilia 2002;8:292.

Ruggeri ZM . Structure of von Willebrand factor and tis function in platelet adhesion and thrombous formation. Best Pract Res Clin Haematol 2001;14:257.

Schwarz HP , Ewenstein B , Turecek PL . The 1st international standard for von Willebrand factor concentrate: More to come? Thromb Haemost 2002;88:376.

Casonato A , Pontara E , Bertomoro A , et al. Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: An alternative to ristocetin cofactor activity? Br J Haematol 2001;112:578.

Federici AB , Mannuci PM . Diagnosis and management of von Willebrand disease. Haemophilia 1999;5:28.

Favaloro EJ , Bukuya M , Martinelli T , et al. Comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates. Thromb Haemost 2002;87:466.

Howard MA , Firkin BG . Ristocetin-a new tool in the investigation of platelet aggregation. Thromb Diathes Heamorrh 1971;26:362.

Murdock PJ , Woodhams BJ , Matthews KB , et al. Thromb Haemost 1997;78:1272.

10.

Vanhoorelbeke K , Cauwenberghs N , Vauterin S , et al. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2000;83:107.

11.

Favaloro EJ . Laboratory assessment as a critical component of the appropriate diagnosis and subclassification of con Willebrand’s disease. Blood Rev 1999;13:185.

12.

Macfarlane DE , Stibbe J , Kirby EP , et al. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975;34:306.

13.

Zuzel M , Nilsson IM , Åberg M . A method for measuring plasma ristocetin cofactor activity. Normal distribution and stability during storage. Thromb Res 1978;12:745.

14.

Miller CH , Platt SJ , Daniele C , et al. Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2002;88:56.